Strategy & Goals

Since establishing the “Sustainability Development Practice Code” (formerly the “Corporate Social Responsibility Practice Code”) in 2014 as the company’s operational guidelines, OBI Pharma has consistently ensured that all employees adhere to commitments for environmental and social sustainability and fulfill information disclosure obligations as a publicly listed company. The company has formed a Sustainability Execution Committee to advance sustainability-related matters, with the Board of Directors serving as the highest guiding authority. Each year, a sustainability plan for the future is proposed, approved by the Board, and incorporated into the next year’s operational guidelines.

Below are OBI Pharma’s sustainability development goals and strategies for 2025, aimed at enhancing the company’s competitive edge in sustainable operations and fulfilling commitments to environmental and social responsibilities.

	Strategy	Goals
Research and Innovation	From research and development to market launch, a comprehensive management system is established for each stage, emphasizing drug safety, novelty, and efficacy.	Develop innovative, effective, and safe pharmaceuticals to provide new treatment options for cancer patients with unmet needs, aiming to improve health and enhance quality of life.
Intellectual Property Management	Establish a global patent strategy at the inception of product research and development. Maintain a rigorous and efficient global patent portfolio for each core product to preserve a high level of competitive advantage. Monitor and respond to evolving intellectual property regulations in various countries to strengthen intellectual property protection.	Patent management and strategy for intellectual property serve as key indicators of new drug competitiveness. Integrating with the company’s overall development strategy, these efforts aim to explore new domains, innovate business models, and maximize intellectual property revenues.
Culture of Integrity	The company has established stringent policies, management practices, and preventive measures, along with audit and reporting mechanisms, requiring biannual reports to the Board of Directors on execution and oversight. An employee Code of Conduct mandates strict self-discipline and prohibits accepting improper gifts and hospitality. For managers and directors, the company has defined “Ethical Conduct Guidelines” and “Code of Ethics for Directors and Managers,” addressing conflicts of interest, avoidance of personal gain, adherence to confidentiality, legal compliance, and protection of company assets. Collaboration or transactions with external vendors require careful evaluation of their legality, integrity, and reputation, and must adhere to the company’s integrity management policies, implementing supply chain management practices. The company has established a “Whistleblower Handling Procedure” as a channel for reporting violations of integrity and regulations.	The company’s core values emphasize integrity and transparency, which are implemented in corporate governance and risk management mechanisms. This ensures honest management and aims to prevent occurrences of unethical practices such as corruption, improper benefit transfers, and anti-competitive behavior.
Legal Compliance	Regularly promote awareness among employees and establish audit mechanisms to continuously review compliance; promptly address and enforce improvements upon detecting issues. Monitor legal and environmental changes, regularly assess regulations, evaluate their impact on the company, and develop and implement countermeasures. Audit adherence to internal standards across various departments and implement follow-up monitoring and corrective actions based on audit results.	OBI Pharma has adhered to the rule of law, with legal compliance being a fundamental operational requirement. In the face of future challenges, the company will continue to ensure regulatory adherence and strengthen the management of legal risks.
Information Disclosure	The company strictly adheres to the “Corporate Governance Practice Code for Listed and OTC Companies” and relevant regulations, formulating an information disclosure policy. In addition to appointing dedicated personnel for handling significant disclosures, information is regularly announced on the public information observatory and the company’s official website. Information disclosure aims to be open, transparent, and timely, ensuring investors are well-informed about the company’s dynamics and development. The company is committed to fulfilling its basic responsibilities as a public issuer and plans to enhance its international reputation and global competitiveness. The company has established the “Corporate Governance Practice Code” and the “Sustainability Development Practice Code” to strengthen information disclosure and enhance transparency.	OBI Pharma firmly believes that timely and transparent information disclosure is fundamental to earning investor trust and fulfilling the responsibilities of a publicly listed company. In addition to complying with relevant regulations for immediate information release and designating personnel for handling significant disclosures, the company will, when necessary, issue press releases or hold press conferences to explain recent developments and the company’s position, while continually updating information. The company also conducts annual earnings calls to proactively discuss progress with investors, media, and the public, maintaining constructive interaction. This approach ensures compliance with governance practices, strengthens communication with stakeholders, and seeks to gain investor trust and support.
Information Security	Regularly conduct information security risk assessments to continuously strengthen information security management systems and technologies. Organize specialized information security training for IT personnel or participate in external training; also provide general information security awareness education for all employees on a regular basis. To prevent cyber threats and attacks, implement network security protection, establish backup mechanisms for critical systems, conduct disaster recovery drills, introduce multi-factor authentication, employ disk encryption, deploy endpoint protection, and integrate Content Delivery Network (CDN) services to enhance the protection of company web applications and mitigate denial-of-service attacks. Join the government-operated TW-ISAC intelligence platform and, in 2023, become a member of the Taiwan Information Security Executive Alliance to deepen intelligence sharing.	With the increasing global threat of cyberattacks, effectively preventing network attacks and protecting personal and corporate data and confidentiality requires a comprehensive approach. This includes focusing on network security, system security, application security, data encryption, identity authentication, and cloud security. Beyond enhancing cybersecurity infrastructure, it is crucial to conduct regular security assessments and improve response capabilities to safeguard against and mitigate the impact of cybersecurity incidents on the company’s finances, operations, and confidential information.
Labor-Management Harmony	Provide labor conditions and diverse welfare measures that exceed the minimum standards set by labor laws, including retirement benefits, maternity care, and vacation policies. Monitor market trends and adjust salary structures and designs as needed, determining salary increases based on performance evaluations. Comply with legal requirements for labor and health insurance, and offer group insurance and occupational injury insurance to protect employees and their families. Promote physical well-being, leisure, and sports, with policies encouraging and subsidizing employee club activities, and receive the “Sports Enterprise Certification” from the Ministry of Education’s Sports Administration. Establish multiple channels and grievance mechanisms for employees to express their concerns, fostering a communicative and harmonious environment. Set up labor-management meetings as a platform for communication between employees and management.	OBI Pharma is committed to establishing itself as a “happy enterprise” in the biotechnology sector. The company strives to create a safe and friendly work environment, eliminating workplace harassment, discrimination, and bullying. It adheres to statutory labor conditions such as the Labor Standards Act, considers gender and diversity in promotions and talent development, and offers employees and their families security, health management, and welfare policies to attract and retain exceptional talent in pursuit of the company’s vision.
Talent Development and Selection	Establish educational and training systems and encourage employee further education, providing opportunities for both domestic and international advancement. Offer diverse promotion pathways tailored to different job functions and levels. The company’s salary structure is competitive, aimed at attracting and retaining top talent. Implement a reward system to provide immediate recognition for outstanding employee performance. Develop an international internship program to train future talent in the biotechnology industry. 6. Encourage and increase the rate of internal employees filling vacant positions.	The company emphasizes transparency, fairness, and merit-based hiring in its talent management. Once hired, employees are supported in enhancing their professional knowledge and skills through comprehensive training, aimed at improving performance and achievements. The company fosters a culture of self-directed learning and encourages employees to plan their individual career development.
Climate Strategy	Starting September 2024, continue the greenhouse gas inventory initiated in 2023 and obtain certification from an external third-party organization. The results will serve as the basis for tracking and setting targets related to the Task Force on Climate-related Financial Disclosures (TCFD) indicators. Climate change risks will be incorporated into the sustainability report tracking targets, requiring regular assessments and board reports. Strategies will be adjusted in response to government policies. Wastewater, waste, and hazardous materials management must comply with legal procedures and be handled by qualified contractors, with regular reporting to regulatory authorities. The workplace will adopt water and energy-saving facilities whenever possible, and employees will be continuously educated on energy-saving and carbon reduction measures, with a focus on practical implementation in daily life.	In alignment with our responsibilities as global citizens and in response to government sustainability policies, we plan to effectively control greenhouse gas emissions and implement reduction strategies to mitigate the impact of greenhouse gases on the Earth’s greenhouse effect and climate change. We emphasize resource recycling and reuse, pollution prevention, and have defined relevant environmental responsibilities and strategies to achieve energy savings, carbon reduction, and our sustainability goals.

Strategy & Goals​

Strategy & Goals​

Strategy & Goals